-
![Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof](/abs-image/US/2012/05/29/US08188114B2/abs.jpg.150x150.jpg)
1.发明授权Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof 有权吡咯并[2,3-C]吡啶衍生物及其制备方法公开(公告)号：US08188114B2
公开(公告)日：2012-05-29
申请号：US12613763
申请日：2009-11-06
Applicant: Jae-Gyu Kim , Byung-Nak Ahn , Hyouk-Woo Lee , Suk-Won Yoon , Young-Ae Yoon , Dong-Hoon Kim , Chan-Sun Park , Seok-Hee Han , Myung-Hun Cha , Heui II Kang , Sun-Young Jang
Inventor： Jae-Gyu Kim , Byung-Nak Ahn , Hyouk-Woo Lee , Suk-Won Yoon , Young-Ae Yoon , Dong-Hoon Kim , Chan-Sun Park , Seok-Hee Han , Myung-Hun Cha , Heui II Kang , Sun-Young Jang
IPC: A61K31/437 , C07D471/04 , A61P1/04
CPC classification number: C07D471/04
Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.
Abstract translation: 本发明提供新的吡咯并[2,3-c]吡啶衍生物或其药学上可接受的盐，其制备方法和包含其的组合物。 本发明的吡咯并[2,3-c]吡啶衍生物或其药学上可接受的盐具有优异的质子泵抑制作用，具有获得可逆质子泵抑制作用的能力。
-
2.发明授权Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same 失效针对人肿瘤坏死因子α的单克隆抗体的抗体可变区和编码其的基因公开(公告)号：US07196177B2
公开(公告)日：2007-03-27
申请号：US11376338
申请日：2006-03-16
Applicant: Heui II Kang , In Young Ko , Moo Young Song , Chang Seok Kim , Sang Koo Park , Jae Sun Lee , Tae Hyoung Yoo , Kang In Na
Inventor： Heui II Kang , In Young Ko , Moo Young Song , Chang Seok Kim , Sang Koo Park , Jae Sun Lee , Tae Hyoung Yoo , Kang In Na
CPC classification number: C07K16/241 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92
Abstract: An antibody variable region of a monoclonal antibody specifically binding to human tumor necrosis factor-α contains at least one of a heavy chain variable region and a light chain variable region having specific complementarity determining regions therein. A nucleic acid molecule encoding the same, a recombinant vector containing the nucleic acid molecule, and a cell transformed with the recombinant vector are also provided.
Abstract translation: 与人肿瘤坏死因子-α特异性结合的单克隆抗体的抗体可变区含有其中具有特异性互补决定区的重链可变区和轻链可变区中的至少一个。 还提供了编码该核酸分子的核酸分子，含有核酸分子的重组载体和用重组载体转化的细胞。
-
![PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF](/abs-image/US/2010/03/18/US20100069430A1/abs.jpg.150x150.jpg)
3.发明申请PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF 有权吡咯并[2,3-C]吡啶衍生物及其制备方法公开(公告)号：US20100069430A1
公开(公告)日：2010-03-18
申请号：US12613763
申请日：2009-11-06
Applicant: Jae-Gyu KIM , Byung-Nak Ahn , Hyouk-Woo Lee , Suk-Won Yoon , Young-Ae Yoon , Dong-Hoon Kim , Chan-Sun Park , Seok-Hee Han , Myung-Hun Cha , Heui-II Kang , Sun-Young Jang
Inventor： Jae-Gyu KIM , Byung-Nak Ahn , Hyouk-Woo Lee , Suk-Won Yoon , Young-Ae Yoon , Dong-Hoon Kim , Chan-Sun Park , Seok-Hee Han , Myung-Hun Cha , Heui-II Kang , Sun-Young Jang
IPC: A61K31/437 , C07D471/04 , A61P1/04
CPC classification number: C07D471/04
Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.
Abstract translation: 本发明提供新的吡咯并[2,3-c]吡啶衍生物或其药学上可接受的盐，其制备方法和包含其的组合物。 本发明的吡咯并[2,3-c]吡啶衍生物或其药学上可接受的盐具有优异的质子泵抑制作用，具有获得可逆质子泵抑制作用的能力。
-
-
Search Results
3
records
(took 0.016 seconds)
